| Patents for C07D 417 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group (62,773) |
|---|
| 08/04/2010 | CN101796045A New chemical compounds |
| 08/04/2010 | CN101796043A Benzofuran- and benzo[b]thiophene-2-carboxylic acid amide derivatives and use thereof as histamine 3 receptor modulators |
| 08/04/2010 | CN101796040A modulators of pharmacokinetic properties of therapeutics |
| 08/04/2010 | CN101792440A Quinazolinone derivatives, preparation and application thereof |
| 08/04/2010 | CN101792439A Method for synthesizing thiacloprid amide by using thiacloprid |
| 08/04/2010 | CN101792438A Method for synthesizing 1-substituted-1,2,3-tolyltriazole |
| 08/03/2010 | US7767819 Thiazolylimidazole derivatives and their use as inhibitors of microsomal triglyceride transfer protein |
| 08/03/2010 | US7767812 Crystals of pyrimidine compound and process for producing the same |
| 08/03/2010 | US7767706 Substituted aryl acylthioureas and related compounds; inhibitors of viral replication |
| 08/03/2010 | US7767702 Combinations of oxazolidinones such as rivaroxaban with a platelet aggregation inhibitor such as a clopidogrel for the prophylaxis and/or treatment of thromboembolic disorders |
| 08/03/2010 | US7767701 protein serine/threonine kinase inhibitors such as 2-(2-Chloro-5-fluoro-phenylimino)-5-(2,3-dihydro-benzo[1-6]dioxin-6-ylmethylene)-thiazolidin-4-one, used for treating autoimmune diseases, HIV, cancer, anemia myelodysplastic syndrome and thrombocytopenia |
| 08/03/2010 | US7767684 N-acylsulfonamide derivatives; BCL-X1 protein inhibitors; anticarcinogenic agents; bladder cancer; for example, N-(4-(4-((4'-chloro(1,1'-biphenyl)-2-yl)methyl)piperazin-1-yl)benzoyl)-4-(((1R)-3-(dimethylamino)-1-((phenylsulfanyl)methyl)-propyl)amino)-3-nitrobenzenesulfonamide |
| 08/03/2010 | US7767681 chemokine receptor modulators such as N-[4-(2-methoxy-5-propoxyphenyl)thiazol-2-yl]-N'-[4-(2-morpholin-4-ylethyl)piperazin-1-yl]urea, used for the prevention or treatment of asthma, arthritis, allergies, autoimmune diseases, atherosclerosis or angiogenesis |
| 08/03/2010 | US7767676 2-amino-3,6-dihydro-4-dimethyl-amino-6-ethyl-1,3,5-triazine hydrochloride; advanced glycosylation end-products inhibitor;antidiabetic, insulin resistance, neurodegenerative disorders, renal complications, atherosclerosis, angiopathy |
| 08/03/2010 | US7767672 Aminopyrimidines useful as kinase inhibitors |
| 08/03/2010 | US7767670 Substituted 3-carboxamido isoxazoles as kinase modulators |
| 08/03/2010 | US7767669 inhibitors of phosphatidyl inositol (PI) 3-kinase, such as 4-(1H-indazol-5-ylamino)-6- (4-methoxy-3- methylphenyl)-2-morpholin- 4-ylpyrimidine-5-carboxylic acid, used for the treatment of breast cancer |
| 08/03/2010 | US7767667 Pesticidal heterocycles |
| 08/03/2010 | US7767665 1,3-benzothiazinone derivatives and use thereof |
| 08/03/2010 | US7767432 Strain of sorangium cellulosum for generation of epothilone derivatives; antitumor agents |
| 08/03/2010 | CA2526228C Quinoline derivatives as phosphodiesterase inhibitors |
| 08/03/2010 | CA2512926C Methods and compositions for inhibition of angiogenesis |
| 08/03/2010 | CA2459311C 17beta-hydroxysteroid dehydrogenase type 3 inhibitors for the treatment of androgen dependent diseases |
| 08/03/2010 | CA2425165C A process for the preparation of bis-benzazolyl compounds |
| 07/29/2010 | WO2010085684A1 Compositions and methods for inhibition of the jak pathway |
| 07/29/2010 | WO2010085528A1 Bridged and fused antidiabetic compounds |
| 07/29/2010 | WO2010085525A1 Bridged and fused heterocyclic antidiabetic compounds |
| 07/29/2010 | WO2010085522A1 Pentafluorosulpholane-containing antidiabetic compounds |
| 07/29/2010 | WO2010085246A1 2,4-diamino-1,3,5-triazine and 4, 6-diamino-pyrimidine derivatives and their use as aggrecanase inhibitors |
| 07/29/2010 | WO2010084979A1 Benzodiazepin-2-on derivatives |
| 07/29/2010 | WO2010084402A2 Heterocyclic compounds as phosphodiesterase inhibitors |
| 07/29/2010 | WO2010084152A1 Novel bicyclic antibiotics |
| 07/29/2010 | WO2010084067A2 Insecticidal compounds |
| 07/29/2010 | WO2010083720A1 Optical pure quinazoline compounds |
| 07/29/2010 | WO2010065579A3 Fungicidal heterocyclic compounds |
| 07/29/2010 | WO2010038154A3 Polymorphic forms of rosiglitazone hydrogensulfate and processes for their preparation |
| 07/29/2010 | WO2009158467A3 Di-substituted phenyl compounds as phosphodiesterase 10 inhibitors |
| 07/29/2010 | US20100190980 Pyrazinamide compound |
| 07/29/2010 | US20100190822 Pharmaceutical Compositions As Inhibitors of Dipeptidyl Peptidase-IV (DPP-IV) |
| 07/29/2010 | US20100190782 Compounds and methods of use |
| 07/29/2010 | US20100190780 Sigma receptor inhibitors |
| 07/29/2010 | US20100190779 Viral polymerase inhibitors |
| 07/29/2010 | US20100190777 Compounds and methods for kinase modulation, and indications therefor |
| 07/29/2010 | US20100190766 Antibacterial agents |
| 07/29/2010 | US20100190763 Poly (ADP-Ribose) Polymerase (PARP) Inhibitors |
| 07/29/2010 | US20100190747 Fused ring compound and use thereof |
| 07/29/2010 | US20100189762 Triarylmethane analogs and their use in treating cancers |
| 07/29/2010 | US20100189687 Modulators of pharmacokinetic properties of therapeutics |
| 07/29/2010 | CA2750047A1 Novel bicyclic antibiotics |
| 07/29/2010 | CA2749930A1 Bridged and fused heterocyclic antidiabetic compounds |
| 07/29/2010 | CA2749891A1 Bridged and fused antidiabetic compounds |
| 07/29/2010 | CA2749700A1 Benzodiazepin-2-on derivatives |
| 07/29/2010 | CA2749663A1 Pentafluorosulpholane-containing antidiabetic compounds |
| 07/29/2010 | CA2749217A1 Compositions and methods for inhibition of the jak pathway |
| 07/28/2010 | EP2209779A1 Heterocyclic urea and thiourea derivatives and methods of use thereof |
| 07/28/2010 | EP2209778A1 Pyridin-2 -yl-amino-i, 2, 4 -thiadiazole derivatives as glucokinase activators for the treatment of diabetes mellitus |
| 07/28/2010 | EP2209777A2 Thiazol derivatives for treating cancer |
| 07/28/2010 | EP2209761A1 Diphenyl substituted cycloalkanes |
| 07/28/2010 | EP2029546B1 Aryl-substituted heterocycles, and use thereof |
| 07/28/2010 | EP1694668B1 4-[(arylmethyl)aminomethyl]piperidine derivatives, preparation thereof and application of same in therapeutics |
| 07/28/2010 | EP1458392B9 Acridones as inhibitors of impdh enzyme |
| 07/28/2010 | CN1974596B 丙型肝炎病毒抑制剂 Hepatitis C virus inhibitors |
| 07/28/2010 | CN1788000B Phthalazinone derivatives |
| 07/28/2010 | CN101790526A 5-heteroaryl substituted indazoles as kinase inhibitors |
| 07/28/2010 | CN101790524A 抗病毒化合物 Antiviral compounds |
| 07/28/2010 | CN101790515A trans-3-aza-bicyclo[3.1.0]hexane derivatives |
| 07/28/2010 | CN101790513A 1,3-dihydroisoindole derivatives |
| 07/28/2010 | CN101787020A Organic conjugated molecule capable of being processed by solution and application thereof in solar cells |
| 07/28/2010 | CN101787019A Quinazoline derivatives |
| 07/28/2010 | CN101787017A Optical pure quinazoline compound |
| 07/28/2010 | CN101787000A M-stage kinesin inhibitor |
| 07/27/2010 | US7763733 such as (2S,3S,5S)-2,5-bis-[N [N [[N-methyl-N-[(2-isopropyl-4-thiazolyl)methyl]amino]carbonyl]valinyl]amino]-1,6-diphenyl-3-hydroxyhexane, used for the treatment of human immunodeficiency virus infection |
| 07/27/2010 | US7763641 such as [(1S,2R)-2-hydroxy-3-[N-[4-(2-methylaminothiazol-4-yl)phenylsulfonyl]-N-(2-methylpropyl)amino]-1-(phenylmethyl)propyl]carbamic acid, [(3R,3aS,6aR)-hexahydrofuro[2,3-b]furan-3-yl]ester, used for treating human immunodeficiency virus infections |
| 07/27/2010 | US7763630 pyrimidinone compounds such as N-(4-Fluorobenzyl)-5-hydroxy-1-methyl-6-oxo-2-(tetrahydrofuran-3-yl)-1,6-dihydropyrimidine-4-carboxamide, used for treating human immunodeficiency virus (HIV) and acquired immune deficiency syndrome (AIDS) |
| 07/27/2010 | US7763614 Isoquinoline potassium channel inhibitors |
| 07/27/2010 | US7763602 Drug resistant Mycobacterium tuberculosis |
| 07/27/2010 | CA2448319C Cytotoxins, prodrugs, linkers and stabilizers useful therefor |
| 07/27/2010 | CA2436659C Cannabinoid receptor ligands |
| 07/22/2010 | WO2010083404A2 Linked myc-max small molecule inhibitors |
| 07/22/2010 | WO2010083199A1 Benzthiazole inhibitors of poly(adp-ribose)polymerase |
| 07/22/2010 | WO2010083141A1 Bicyclic compounds for the reduction of beta-amyloid production |
| 07/22/2010 | WO2010082563A1 Cyclic compound having hetero atom |
| 07/22/2010 | WO2010081904A1 4 ( 1h) -pyridinone derivatives and their use as antimalaria agents |
| 07/22/2010 | WO2010081755A1 Novel herbicides |
| 07/22/2010 | WO2010081387A1 N-substituted phenyl-3-methylene heterocyclic aryl-2,5-dimethylpyrrole compounds and anti-hiv/aids uses thereof |
| 07/22/2010 | WO2010028338A3 Novel compounds as cannabinoid receptor ligands |
| 07/22/2010 | WO2010012745A3 Benzimidazoles |
| 07/22/2010 | WO2010011853A3 Beta-and gamma-amino-isoquinoline amide compounds and substituted benzamide compounds |
| 07/22/2010 | WO2010007046A3 Heteroaryl derivatives as dgat1 inhibitors |
| 07/22/2010 | WO2009137339A3 Therapeutic n-aryl or n-heteroaryl pyrazolidine and pyrazolidinone derivatives |
| 07/22/2010 | US20100184981 2,3-dihydro-iminoisoindole derivatives |
| 07/22/2010 | US20100184808 3-aza-bicyclo[3.3.0]octane compounds |
| 07/22/2010 | US20100184794 Fused heterocyclic compound |
| 07/22/2010 | US20100184772 Sulfonamide substituted pyrazoline compounds, their preparation and use as cb1 modulators |
| 07/22/2010 | US20100184766 Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases |
| 07/22/2010 | US20100184754 Quinolinone derivatives |
| 07/22/2010 | US20100184753 Ion Channel Modulators and Methods of Uses |
| 07/22/2010 | US20100184750 Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases |
| 07/22/2010 | US20100184749 Benzothiadiazine compounds and their use |
| 07/22/2010 | US20100184740 Substituted oxazolidinones and their use |